Parkworth Wealth Management’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2
Closed -$121 1361
2025
Q1
$121 Buy
+2
New +$129 ﹤0.01% 884

Other funds holding CNMD

Parkworth Wealth Management's CNMD Position: Q2 2025 in Review

Parkworth Wealth Management sold out of CONMED (CNMD) in Q2 2025, closing a stake of 2 shares — an estimated $121 sold.

Parkworth Wealth Management first reported a position in CNMD in Q1 2025 and held it in 1 quarter. The position peaked at $121 in Q1 2025. 276 funds tracked by Wall St. Rank hold CNMD as of Q2 2025.

  • Parkworth Wealth Management reported no remaining CONMED position as of Q2 2025 after selling out during the quarter.
  • Parkworth Wealth Management sold 2 CONMED shares in Q2 2025, an estimated $121.
  • Parkworth Wealth Management first reported a position in CONMED in Q1 2025 and held it in 1 quarter.
  • Parkworth Wealth Management's CONMED position peaked at $121 in Q1 2025.
  • 276 funds tracked by Wall St. Rank held CONMED as of Q2 2025.

Based on Parkworth Wealth Management's 13F filing for Q2 2025, filed 13 Aug 2025.